查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552476

全球結核病診斷市場：到 2033 年的機會和策略

Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 353 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2018 年全球結核病診斷市值為 17.484 億美元，到 2023 年複合年成長率將超過 3.0%

核酸檢測的採用率有所提高

核酸檢測的廣泛採用支持了結核病診斷市場的成長。結核菌核酸增幅檢查(NAAT) 用於鑑定痰液和其他呼吸道檢體中的結核分枝桿菌複合體 (MTBC) DNA（去氧核糖核酸）。與傳統顯微鏡相比，核酸檢測具有準確度更高、觀察更快的優點。例如，2022年，根據羅德島州衛生部公佈的資料，羅德島州衛生實驗室（RISHL）已能夠在呼吸道檢體中檢測到結核分枝桿菌複合體（MTB-complex）DNA的存在。所使用的自動化分子診斷測試NAAT 利用Cepheid Xpert MTB/RIF 測定。此外，2021 年 2 月，世界衛生組織 (WHO) 發布了用於診斷結核病和抗藥性的新分子檢測的最新資訊。新技術更新包括用於檢測結核病以及利福平和異煙肼抗藥性的中等複雜性自動化核酸增幅檢查（NAAT）；以及用於檢測Pyrazinamide抗藥性的基於高複雜性雜合反應的NAAT。因此，核酸檢測的日益普及支持了結核病診斷市場的成長。

目錄

第1章執行摘要

  • 結核病診斷 - 市場吸引力和宏觀經濟狀況

第2章 目錄

第3章表格一覽

第4章圖表一覽

第5章 報告結構

第6章市場特徵

  • 一般市場定義
  • 概述
  • 結核病診斷市場定義與細分
  • 市場區隔：按測試類型
    • 放射線檢查
    • 核酸檢測
    • 細胞激素檢測試驗
    • 抗藥性測試
    • 皮膚測試/曼圖測試（TST）
    • 血液檢查/血清學檢查
    • 塗片顯微鏡檢查
    • 文化測試
    • 其他檢查類型
  • 市場區隔：依疾病階段
    • 潛伏性結核病
    • 活動性結核病
  • 市場區隔：按最終用戶
    • 醫院和診斷實驗室
    • 醫生辦公室檢查室
    • 參考實驗室
    • 學術研究設施

第7章 主要市場趨勢

  • 用於結核病診斷的次世代定序（NGS）平台
  • 先進診斷解決方案的新產品創新
  • 介紹 T 細胞檢測以提高結核病檢測的準確性和可靠性
  • 提高基於人工智慧（AI）的結核病診斷的準確性
  • 使用行動裝置增強資源有限環境中的存取能力
  • 市場參與者之間的策略合作以增強診斷的可及性
  • 技術進步正在改變結核病檢測的面貌
  • 結核病微創檢測血液檢測簡介

第8章結核病診斷市場-宏觀經濟情景

  • COVID-19 的影響：結核病診斷市場
  • 烏克蘭戰爭的影響：結核病診斷市場
  • 高通膨的影響：結核病診斷市場

第9章世界市場規模與成長

  • 市場規模
  • 2018-2023 年市場成長表現
    • 2018-2023年市場促進因素
    • 2018-2023年市場限制因素
  • 市場成長預測，2023-2028，2033F
    • 2023-2028年市場促進因素
    • 2023-2028年市場限制因素

第10章全球結核病診斷市場：細分

  • 全球結核病診斷市場：按測試類型分類的表現和預測，2018-2023、2028F、2033F
  • 全球結核病診斷市場：2018-2023、2028F、2033F分階段表現與預測
  • 全球結核病診斷市場：最終用戶的表現和預測，2018-2023、2028F、2033F

第11章結核病診斷市場：區域與國家分析

  • 全球結核病診斷市場：按地區分類的表現和預測，2018-2023、2028F、2033F
  • 全球結核病診斷市場：按國家分類的績效和預測，2018-2023、2028F、2033F

第12章亞太市場

第13章西歐市場

第14章 東歐市場

第15章 北美市場

第16章 南美洲市場

第17章 中東市場

第18章 非洲市場

第19章 競爭格局及公司概況

  • 公司簡介
  • Becton, Dickinson and Company
  • Qiagen NV
  • F. Hoffman-La Roche Ltd
  • BioMerieux SA
  • Danaher Corporation（Cepheid, Inc.）

第20章 其他大型創新企業

  • Abbott Laboratories, Inc
  • Bio-Rad Laboratories, Inc
  • Thermo Fisher Scientific, Inc
  • PerkinElmer, Inc
  • Bio-Techne Corporation
  • Hologic, Inc
  • Laboratory Corporation
  • Siemens Healthineers
  • Akonni Biosystems Inc
  • Hain Lifescience GmbH
  • Creative Diagnostics
  • Lionex GmbH
  • Genedrive PLC
  • Mylab Discovery Solutions Pvt. Ltd
  • AdvaCare Pharma

第21章 競爭基準化分析

第22章競爭對手儀表板

第23章 重大併購

  • Molbio Diagnostics Acquired Prognosys Medical Systems
  • SD Biosensor Acquired Relab
  • Hologic Inc. Acquired Mobidiag Oy
  • PerkinElmer Acquired Oxford Immunotec
  • Thermo Fisher Scientific Acquired Mesa Biotech Inc.

第24章機遇與策略

  • 2028 年全球結核病診斷市場：提供新機會的國家
  • 2028 年全球結核病診斷市場：提供新機會的細分市場
  • 2028 年全球結核診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第25章結核病診斷市場：結論與建議

  • 結論
  • 推薦
    • 產品
    • 地方
    • 價格
    • 晉升
    • 人們

第26章附錄

簡介目錄
Product Code: o&s1333

Tuberculosis diagnostics refers to a tool or test with high sensitivity and specificity for tuberculosis (TB) diagnosis. Tuberculosis diagnostics are used to identify acid-fast bacilli (AFB) in clinical specimens and to detect tuberculosis.

TB is an infectious disease that primarily affects the lungs and is caused by the bacterium Mycobacterium tuberculosis. Imaging studies, sputum microscopy, culture and molecular testing are some of the tests and techniques used in TB diagnoses. The purpose of TB diagnostics is to promptly and precisely identify people who have active TB so that they can get the right care and avoid spreading it to others.

The global tuberculosis diagnostics market was valued at $1,748.4 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 3.0%

Rise In The Adoption Of Nucleic Acid Testing

During the historic period, the rise in the adoption of nucleic acid testing supported the growth of the tuberculosis diagnostics market. A nucleic acid amplification test (NAAT) for tuberculosis (TB) is used to identify Mycobacterium tuberculosis complex (MTBC) DNA (deoxyribonucleic acid) in sputum or other respiratory samples. The nucleic acid testing provides benefits such as greater accuracy than conventional microscopy techniques and faster findings. For example, in 2022, according to data published by the State of Rhode Island Department of Health, it has been observed that Rhode Island State Health Laboratory (RISHL) utilizes the Cepheid Xpert MTB/RIF assay for NAAT, an automated molecular diagnostic test that is used to detect the presence of Mycobacterium tuberculosis complex (MTB-complex) DNA in respiratory specimens. Further, in February 2021, the World Health Organization (WHO) announced updates on new molecular assays for the diagnosis of tuberculosis (TB) and drug resistance. The updates on new technologies included moderate complexity automated Nucleic Acid Amplification Tests (NAATs), for detection of TB and resistance to rifampicin and isoniazid, low complexity automated NAATs for detection of resistance to isoniazid and second-line anti-TB agents and high complexity hybridization-based NAATs for detection of resistance to pyrazinamide. Therefore, the rise in the adoption of nucleic acid testing supported the growth of the tuberculosis diagnostics market.

Next Generation Sequencing (NGS) Platforms For TB Diagnostics

The use of next-generation sequencing (NGS) platforms to detect drug-resistant strains of tuberculosis (TB) at a high throughput and with higher speed and accuracy is emerging as a potential trend in TB diagnostics. Companies operating in the tuberculosis diagnostics market are focusing on next generation sequencing platform for rapidly diagnosing drug-resistant tuberculosis. For example, in April 2024, QIAGEN, a German provider of sample and assay technologies for molecular diagnostics, applied testing, academic research and pharmaceutical research, launched the QIAseq xHYB Mycobacterium tuberculosis Panel for research use, a new tool in the fight against tuberculosis (TB), the world's leading infectious disease killer. The QIAseq xHYB Mycobacterium tuberculosis Panel represents a major advancement in solving the problem of bacterial WGS from complex host samples, using next-generation sequencing (NGS). Further, in March 2023, Illumina, a US-based biotechnology company and GenoScreen, a France-based genomics company, introduced a new tuberculosis test that combines products from Illumina with the GenoScreen Deeplex Myc-TB assay, a targeted next-generation sequencing (NGS)-based test for Tuberculosis (TB). This test can detect TB mycobacteria, as well as more than 100 non-TB mycobacterial species.

The global tuberculosis diagnostics market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 28.3% of the total market in 2023.

Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global tuberculosis diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for tuberculosis diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The tuberculosis diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider tuberculosis diagnostics market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by test type, by disease stage and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the tuberculosis diagnostics market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by test type, by disease stage and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for tuberculosis diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests; Other Test Types
  • 2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis
  • 3) By End User: Hospitals And Diagnostic Laboratories; Physician's Office Laboratories; Reference Laboratories; Academics And Research Facilities
  • Companies Mentioned: Beckton, Dickinson and Company; Qiagen N.V.; F. Hoffmann-La Roche AG; bioMerieux SA.; Danaher Corporation (Cepheid, Inc.)
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; tuberculosis diagnostics indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Tuberculosis Diagnostics - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Tuberculosis Diagnostics Market Definition And Segmentations
  • 6.4 Market Segmentation By Test Type
    • 6.4.1 Radiographic Test
    • 6.4.2 Nucleic Acid Testing
    • 6.4.3 Cytokine Detection Test
    • 6.4.4 Drug Resistance Test
    • 6.4.5 Skin Test/Mantoux Test (TST)
    • 6.4.6 Blood Test/Serology Test
    • 6.4.7 Smear Microscopy
    • 6.4.8 Cultured-Based Tests
    • 6.4.9 Other Test Types
  • 6.5 Market Segmentation By Disease Stage
    • 6.5.1 Latent Tuberculosis
    • 6.5.2 Active Tuberculosis
  • 6.6 Market Segmentation By End-User
    • 6.6.1 Hospitals And Diagnostic Laboratories
    • 6.6.2 Physician's Office Laboratories
    • 6.6.3 Reference Laboratories
    • 6.6.4 Academics And Research Facilities

7 Major Market Trends

  • 7.1 Next Generation Sequencing (NGS) Platforms For TB Diagnostics
  • 7.2 New Product Innovations For Advanced Diagnostics Solutions
  • 7.3 Introduction Of T Cell Tests To Transform TB Detection With Precision And Reliability
  • 7.4 Artificial Intelligence (AI)-Based Tuberculosis Diagnostics To Enhance Accuracy
  • 7.5 Use Of Portable Devices To Enhance Access In Resource-Limited Settings
  • 7.6 Strategic Collaborations Among Market Players To Enhance Access To Diagnostics
  • 7.7 Technology Advancements To Transform The Landscape Of TB Detection
  • 7.8 Introduction Of Blood-Based Tests For Minimally Invasive Detection Of TB

8 Tuberculosis Diagnostics Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The Tuberculosis Diagnostics Market
  • 8.2 Impact Of The War In Ukraine On The Tuberculosis Diagnostics Market
  • 8.3 Impact Of High Inflation On The Tuberculosis Diagnostics Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Tuberculosis Diagnostics Market Segmentation

  • 10.1 Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Tuberculosis Diagnostics Market, Regional and Country Analysis

  • 11.1 Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Tuberculosis Diagnostics Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Tuberculosis Diagnostics Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Tuberculosis Diagnostics Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Tuberculosis Diagnostics Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Tuberculosis Diagnostics Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Tuberculosis Diagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Becton, Dickinson and Company
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Qiagen N.V.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 F. Hoffman-La Roche Ltd
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 BioMerieux SA
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Danaher Corporation (Cepheid, Inc.)
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Tuberculosis Diagnostics Market Other Major And Innovative Companies

  • 20.1 Abbott Laboratories, Inc
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
  • 20.2 Bio-Rad Laboratories, Inc
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
  • 20.3 Thermo Fisher Scientific, Inc
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
  • 20.4 PerkinElmer, Inc
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Bio-Techne Corporation
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
  • 20.6 Hologic, Inc
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
  • 20.7 Laboratory Corporation
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
  • 20.8 Siemens Healthineers
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
  • 20.9 Akonni Biosystems Inc
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
  • 20.10 Hain Lifescience GmbH
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
  • 20.11 Creative Diagnostics
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Lionex GmbH
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 Genedrive PLC
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
  • 20.14 Mylab Discovery Solutions Pvt. Ltd
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
  • 20.15 AdvaCare Pharma
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Molbio Diagnostics Acquired Prognosys Medical Systems
  • 23.2 SD Biosensor Acquired Relab
  • 23.3 Hologic Inc. Acquired Mobidiag Oy
  • 23.4 PerkinElmer Acquired Oxford Immunotec
  • 23.5 Thermo Fisher Scientific Acquired Mesa Biotech Inc.

24 Opportunities And Strategies

  • 24.1 Global Tuberculosis Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Tuberculosis Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Tuberculosis Diagnostics Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Tuberculosis Diagnostics Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer